Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane Eye Drops vs Transparent Dressing for Tear Film Protection During General Anesthesia
ChiCTR2600116683Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of perfluorohexyloctane in Exposure keratitis (EK) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Dry Eye Symptom VAS Score, Tear Film Break-Up Time (TBUT) and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
Exposure keratitis (EK)
Beyond the preview
Go deeper on ChiCTR2600116683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116683.